Intrinsic Value of S&P & Nasdaq Contact Us

Eupraxia Pharmaceuticals Inc. EPRXF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
15/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — EPRXF

Eupraxia Pharmaceuticals Inc. (EPRXF) has a market capitalization of $108.29M and trades at $3.04. The 52-week range is 2.9341-6.7764.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-1.58.

The stock has a beta of 1.40, operates in the Healthcare sector.

Trading Data
Current Price$3.04
52-Week Range2.9341-6.7764
Volume800
Avg Volume (30D)2.42K
Market Cap$108.29M
Beta (1Y)1.40
Company
IPO Date2021-08-03
Employees21
CEOJames A. Helliwell FRCPC,
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA29842P1053
Income (Latest Year)
Gross Profit$-209.91K
EBITDA$-37.68M
Operating Income$-37.89M
Net Income$-38.09M
EPS$-1.58
EPS Diluted$-1.58
Shares Outstanding$24.15M
Balance Sheet (Latest Year)
Total Assets$26.72M
Current Assets$26.11M
Cash & ST Investments$25.5M
Total Liabilities$25.55M
Total Debt$13.78M
Net Debt$-11.72M
Total Equity$1.18M
Debt / Equity11.71
Valuation Ratios
P/E Ratio-1.9
P/B Ratio92.04
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message